Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Neoantigen Identification and Response to Adoptive Cell Transfer in Anti-PD-1 Naïve and Experienced Patients with Metastatic MelanomaShoshana T Levi, Amy R Copeland, Shirley Nah, et al.Nature Genetics|March 31, 2009
Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanomaLavanya H Palavalli, Todd D Prickett, John R Wunderlich, et al.Biorxiv : the Preprint Server for Biology|June 4, 2025
Rapid enrichment of progenitor exhausted neoantigen-specific CD8 T cells from peripheral bloodMamduh Khateb, Raina Jung, Stav Leibou, et al.Cancer Discovery|June 6, 2019
Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal CancersMaria R Parkhurst, Paul F Robbins, Eric Tran, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2022
Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous LymphocytesNikolaos Zacharakis, Lutfi M Huq, Samantha J Seitter, et al.Proceedings of the National Academy of Sciences of the United States of America|August 1, 2013
Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanomaJared J Gartner, Stephen C J Parker, Todd D Prickett, et al.Nature Medicine|April 1, 2025
Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trialFrank J Lowery, Stephanie L Goff, Billel Gasmi, et al.Med (New York, N.Y.)|August 25, 2022
Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockadeDouglas C Palmer, Beau R Webber, Yogin Patel, et al.Cancer Immunology Research|June 24, 2022
Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid TumorsSanghyun P Kim, Nolan R Vale, Nikolaos Zacharakis, et al.Science (New York, N.Y.)|February 3, 2022
Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancersFrank J Lowery, Sri Krishna, Rami Yossef, et al.Pageof 6